| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―May―08 |
Adjunctive therapy with lipid-lowering agents in COVID-19: a systematic review and meta-analysis of randomized controlled trials |
Amirmohammad Khalaji, Amir Hossein Behnoush, Sanam Alilou, Malihe Rezaee, Soheil Peiman, Amirhossein Sahebkar |
| 2 |
[GO] |
2021―Dec―13 |
Strong relationship between cholesterol, low-density lipoprotein receptor, Na+/H+ exchanger, and SARS-COV-2: this association may be the cause of death in the patient with COVID-19 |
Erkan Cure, Medine Cumhur Cure |
| 3 |
[GO] |
2021―Oct―25 |
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection |
Stanisław Surma, Maciej Banach, Joanna Lewek |
| 4 |
[GO] |
2021―Oct―04 |
Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management |
Yanlan Xu, Xinyu Yang, Hua Bian, Mingfeng Xia |
| 5 |
[GO] |
2020―Sep―07 |
Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study |
Guyi Wang, Quan Zhang, Xianmei Zhao, Haiyun Dong, Chenfang Wu, Fang Wu, et al. (+8) Bo Yu, Jianlei Lv, Siye Zhang, Guobao Wu, Shangjie Wu, Xiaolei Wang, Ying Wu, Yanjun Zhong |
|
